Form D Explorer

Inspect source fieldsReport a record issue

Form D — Rgenta Therapeutics, Inc.

0001231919-26-001529 · filed Nov 3, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Other Technology filings

Offering

Industry
Other Technology
Exemptions
06b
Reported offering amount
$130,107,279
Reported amount sold
$41,852,307
Minimum investment
$0
Investors
9
Sales commission
$0
Finders' fees
$0

Issuer

Name
Rgenta Therapeutics, Inc.
CIK
1801266
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
—
Address
300 TradeCenter, Suite 6600
Woburn, MA 01801
Phone
781-608-3996

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗